This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Therapeutic Advances in Psoriasis and Psoriatic Arthritis

Therapeutic Advances in Psoriasis and Psoriatic Arthritis

Format

Slide Lecture Series

Time to Complete

30 minutes

Released

June 8, 2017

Expires

June 8, 2018
Add to Queue


Maximum Credits

0.50 / AMA PRA Category 1 CreditTM
0.60 / CE for Nurses
0.50 / CE for Nurse Practitioners (0.42 pharmacology credit)

Accredited Provider



This activity is provided by Forefront Collaborative.

Commercial Supporter

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Program Description

This 30-minute online activity is focused on advances in treatment of psoriasis, trends in biologic use in psoriasis, treat-to-target recommendations, screening of patients with psoriasis for psoriatic arthritis, and treatment of psoriatic arthritis by disease domain. Participants will listen to the audio-recorded presentation and view the slides. They may extend their learning through use of additional resources that are available to download.

This activity is the prework to the live workshop held in conjunction with Maui Derm NP+PA Summer and Fall 2017 meetings. For more information, please go to www.forefrontcollab.com/mauidermnppa. You may also complete this activity without participating in the live workshop.

Intended Audience

The target audience for this educational activity is nurse practitioners and physician assistants who specialize in dermatology. Dermatologists and other clinicians who are members of the healthcare team providing care for patients with psoriasis may benefit from participation in this education.

Educational Objectives

Upon completion of the activity, participants should be able to:

  • Identify advances in biologic therapies for moderate to severe plaque psoriasis
  • Determine the importance of treat-to-target and comparative effectiveness in psoriasis management
  • Screen psoriasis patients for psoriatic arthritis

Fee Information

There is no fee for this educational activity.

Conflict Of Interest Disclosure Policy

Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s).* For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias. Disclosures appear below.

*The ACCME defines a commercial interest as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by or used on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

Faculty

April Armstrong, MD, MPH
Associate Dean for Clinical Research,
Associate Professor of Dermatology,
Director of Clinical Research, Clinical and Translational Science Institute
Director of Clinical Trials and Outcomes Research,
Director of Psoriasis Program,
Department of Dermatology
Keck School of Medicine of USC
Los Angeles, CA

Dr. Armstrong has served as a consultant for Novartis, Sanofi, Regeneron, Pfizer, Celgene, Modernizing Medicine, AbbVie, Lilly, Merck, and Janssen; and as a researcher and speaker for Lilly, AbbVie, and Janssen.

Accredited Provider Disclosure

The following individuals have indicated that neither they nor their spouses/partners have had, in the past 12 months, financial relationship(s) with commercial interests relative to the content of this CME activity:

Miranda Armie and Marianna Shershneva, MD, PhD, of Forefront Collaborative have no financial relationships to disclose relative to the content of this CME activity.

The following individuals have disclosed that they and/or their spouse/partner have had a financial relationship in the past 12 months:

Lilia Zurkovsky, PhD, of Forefront Collaborative: salary and stock ownership from Teva Pharmaceuticals

CME Content Review

The content of this activity was independently peer reviewed. The reviewers of this activity have no relevant financial relationships to disclose.

Credit

0.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Forefront Collaborative designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

0.60

Type

CE for Nurses

Accreditation Statement

The Interstate Postgraduate Medical Association is approved by the California Board of Registered Nursing, Provider Number 6971, for 0.60 contact hours. Each person should retain this certificate for 4 years after the course has been completed. RNs outside of California must verify with their licensing agency for approval of this course.

Credit

0.50

Type

CE for Nurse Practitioners

Accreditation Statement

This activity is approved for 0.50 contact hours of continuing education, which includes 0.42 hours of pharmacology, by the American Association of Nurse Practitioners. Activity ID 17042646. This activity was planned in accordance with AANP CE Standards and Policies.

Disclosure of Unlabeled Use

This continuing medical education activity does not include reference(s) to unlabeled or unapproved uses of drugs.

Disclaimer

The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views or recommendations of Forefront Collaborative.

Instructions

To obtain credit, a score of 75% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact info@forefrontcollab.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue